DBVT · TickerCove

DBVTDBV Technologies S.A.Healthcare · Biotechnologyas of 2026-09-16

Horizon

Issued 2026-09-16 at $11.79 · now $11.79 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, DBVT has typically landed between $8.85 and $16.89 — a range of −24.9% to +43.2% from the issuance price $11.79.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.

Actual close
Typical path (median)
Middle 50% of outcomes
90% range

2,970 overlapping 1 month windows · 2014-10-22 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($11.79) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

52-week range$11.79 · 19% of range

$8.89 low$24.54 high

Trailing 52 weeks to 2026-09-16 — factual context, not a signal.

Base rate up · monthiClimatology base rate that a US-listed stock rises over a month, with its 90% CI and ≈1,408 effective observations. Not a call on this stock — we have no evidence its odds differ.

53.9%

90% CI 51.7%–56.1%

Distribution · month iiThe price-anchored range: typical move (median), and the p90 downside/upside — 90% of similar periods stayed inside these. Ranges, not a prediction of direction.

−5.5%

typical move · IQR 22.3%

−24.9%worst (p90)+43.2%best (p90)

Insider convictioniOpen-market common-stock purchases by company insiders in the last 90 days (grants and option exercises excluded). Historical tendency, not advice — detail below.

conviction buys

0 open-market sales

Congress disclosuresiRecent disclosed congressional trades for this company. Purchase clusters (≥2 members buying within 90 days) historically preceded a modestly higher forward return (+32 bp/mo in 2022–2026, +45 bp/mo in 2015–2021) — a descriptive tendency, not a forecast input. Detail below.

0 buys · 0 sells · 0 members

cluster tilt persisted, ~halved after 2021

Where DBVT has typically landed a month from the 2026-09-16 close of $11.79 — the range is history, not a prediction.

now $11.79 (+0.0%)
typical $11.14 (-5.5%)
middle 50% $9.82–$12.46
90% range $8.85–$16.89

Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 2,970 windows spanning 2014-10-22 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.

Start	Return	Max drop	Max rise
3 worst
2018-11-19	−64.2%	−64.2%	+0.0%
2018-11-21	−62.5%	−62.6%	+1.6%
2018-11-27	−62.0%	−62.0%	+3.4%
3 best
2020-12-16	+141.5%	−8.1%	+141.5%
2025-03-27	+134.5%	+0.0%	+136.8%
2020-12-17	+128.4%	−12.3%	+130.5%

2,970 overlapping windows · 2014-10-22 – 2026-09-16 · not cherry-picked

Seasonality · by month i

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~12 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.

Jan

33%

+6.1%

n=12

Feb

50%

−0.1%

n=12

Mar

50%

+8.0%

n=12

Apr

67%

+8.7%

n=12

May

25%

−2.9%

n=12

Jun

33%

+3.6%

n=12

Jul

42%

+4.1%

n=12

Aug

42%

−2.6%

n=12

Sep

25%

−9.1%

n=12

Oct

18%

−11.4%

n=11

Nov

42%

+1.5%

n=12

Dec

67%

+0.5%

n=12

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Date	Person	Role	Action	Shares @ price	Value	Ownership Δ	vs S&P 1m	vs S&P 6m	Owned after	Filing
2026-07-29	Mohideen Pharis	officer	Sale	464 @ $2.70	$1K	−0.3% of holding	−0.8%	not yet — horizon still open	144,531	Form 4 · filed 2 days after the trade
2026-01-29	Mohideen Pharis	officer	Sale	534 @ $4.86	$3K	−0.4% of holding	+2.4%	−49.4%	144,995	Form 4 · filed 4 days after the trade
2025-12-18	EPIC Bpifrance	other	Sale	1,292,103 @ $4.19	$5.4M	−15.0% of holding	−0.9%	−34.5%	7,303,369	Form 4 · filed 1 day after the trade
2025-12-17	EPIC Bpifrance	other	Sale	2,036,990 @ $4.84	$9.9M	−19.1% of holding	−8.6%	−42.2%	8,635,472	Form 4 · filed 2 days after the trade
2025-12-17	EPIC Bpifrance	other	Sale	40,000 @ $5.28	$211K	−0.5% of holding	−8.6%	−42.2%	8,595,472	Form 4 · filed 2 days after the trade
2025-11-21	Mohideen Pharis	officer	Sale	1,624 @ $2.77	$4K	−1.6% of holding	+32.9%	+20.0%	101,529	Form 4 · filed 4 days after the trade
2025-11-20	Mohideen Pharis	officer	Sale	6,496 @ $2.88	$19K	−5.9% of holding	+41.9%	+16.2%	103,153	Form 4 · filed 5 days after the trade
2025-07-29	Mohideen Pharis	officer	Sale	464 @ $2.22	$1K	−0.4% of holding	−5.0%	+132.5%	109,649	Form 4 · filed 2 days after the trade
2025-05-22	Mohideen Pharis	officer	Sale	397 @ $1.84	$730	−0.4% of holding	−7.2%	+44.5%	110,113	Form 4 · filed 5 days after the trade
2025-01-30	Mohideen Pharis	officer	Sale	600 @ $0.85	$510	−0.5% of holding	−3.5%	+107.9%	110,510	Form 4 · filed 1 day after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

40 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

Date	Person	Role	Action	Shares	Owned after	Filing
2026-01-12	BAKER BROS. ADVISORS LP	director	Option exercise	2,299,656	0	Form 4
2026-01-12	BAKER BROS. ADVISORS LP	director	Option exercise	25,005,240	0	Form 4
2026-01-12	BAKER BROS. ADVISORS LP	director	Option exercise	2,299,656	2,299,656	Form 4
2026-01-12	BAKER BROS. ADVISORS LP	director	Option exercise	25,005,240	25,005,240	Form 4
2025-11-21	Mohideen Pharis	officer	Award / grant	253,000	253,000	Form 4
2025-11-21	Boucinha Virginie	officer	Award / grant	32,000	70,000	Form 4
2025-11-21	Boucinha Virginie	officer	Award / grant	192,000	192,000	Form 4
2025-11-21	Tasse Daniel	director	Award / grant	964,000	964,000	Form 4
2025-11-21	Trapp Kevin Michael	officer	Award / grant	55,000	55,000	Form 4
2025-11-21	Trapp Kevin Michael	officer	Award / grant	316,250	316,250	Form 4
2025-11-21	Mohideen Pharis	officer	Award / grant	44,000	145,529	Form 4
2025-03-27	BAKER BROS. ADVISORS LP	director	Award / grant	2,299,656	2,299,656	Form 4
2025-03-27	BAKER BROS. ADVISORS LP	director	Award / grant	25,005,240	25,005,240	Form 4
2025-03-27	BAKER BROS. ADVISORS LP	director	Award / grant	2,299,656	2,299,656	Form 4
2025-03-27	BAKER BROS. ADVISORS LP	director	Award / grant	25,005,240	25,005,240	Form 4
2025-03-27	BAKER BROS. ADVISORS LP	director	Award / grant	2,299,656	2,299,656	Form 4
2025-03-27	BAKER BROS. ADVISORS LP	director	Award / grant	25,005,240	25,005,240	Form 4
2025-03-27	BAKER BROS. ADVISORS LP	director	Award / grant	2,299,656	2,299,656	Form 4
2025-03-27	BAKER BROS. ADVISORS LP	director	Award / grant	25,005,240	25,005,240	Form 4
2025-03-27	BAKER BROS. ADVISORS LP	director	Award / grant	25,005,240	25,005,240	Form 4
2025-03-27	BAKER BROS. ADVISORS LP	director	Award / grant	25,005,240	25,005,240	Form 4
2025-03-27	BAKER BROS. ADVISORS LP	director	Award / grant	2,299,656	2,299,656	Form 4
2025-03-27	BAKER BROS. ADVISORS LP	director	Award / grant	25,005,240	25,005,240	Form 4
2025-03-27	BAKER BROS. ADVISORS LP	director	Award / grant	2,299,656	2,299,656	Form 4
2025-03-27	BAKER BROS. ADVISORS LP	director	Award / grant	2,299,656	2,299,656	Form 4
2025-03-27	BAKER BROS. ADVISORS LP	director	Award / grant	25,005,240	25,005,240	Form 4
2025-03-27	BAKER BROS. ADVISORS LP	director	Award / grant	2,299,656	2,299,656	Form 4
2025-03-27	BAKER BROS. ADVISORS LP	director	Award / grant	2,299,656	2,299,656	Form 4
2025-03-27	BAKER BROS. ADVISORS LP	director	Award / grant	25,005,240	25,005,240	Form 4
2025-03-27	BAKER BROS. ADVISORS LP	director	Award / grant	2,299,656	2,299,656	Form 4
2025-03-27	BAKER BROS. ADVISORS LP	director	Award / grant	25,005,240	25,005,240	Form 4
2025-03-27	BAKER BROS. ADVISORS LP	director	Award / grant	2,299,656	2,299,656	Form 4
2025-03-27	BAKER BROS. ADVISORS LP	director	Award / grant	25,005,240	25,005,240	Form 4
2025-03-27	BAKER BROS. ADVISORS LP	director	Award / grant	2,299,656	2,299,656	Form 4
2025-03-27	BAKER BROS. ADVISORS LP	director	Award / grant	25,005,240	25,005,240	Form 4
2025-03-27	BAKER BROS. ADVISORS LP	director	Award / grant	25,005,240	25,005,240	Form 4
2025-03-27	BAKER BROS. ADVISORS LP	director	Award / grant	2,299,656	2,299,656	Form 4
2025-03-27	BAKER BROS. ADVISORS LP	director	Award / grant	2,299,656	2,299,656	Form 4
2025-03-27	BAKER BROS. ADVISORS LP	director	Award / grant	25,005,240	25,005,240	Form 4
2024-12-04	Tasse Daniel	director	Award / grant	813,200	813,200	Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Resolves in i

28d remaining

2026-09-173% elapsed2026-10-15

Logged immutably 2026-09-17; scored automatically on 2026-10-15 — no edits, ever.

Earnings & context analysis

These panels are being prepared. They are generated by multiple language models, checked, and stored before display — never written live for a page view. Until a model panel has been generated and reviewed for a company, nothing is shown here, honestly, rather than a placeholder.

Calibration i

Every forecast is logged when made and scored when the month is up. The record is shown from the day it starts — young and honest.

How scoring works →

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

Reported insider & political trades

Congressional disclosures

Seasonality · by month i